SCHEMBL18927263

SCHEMBL18927263

CC1=NC(c2cc(Br)ccc2C)(C2CCC(C)CC2)N=C1N

nearest known ligand 0.44

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.44
APP P05067 14/20 0.44
KCNH2 Q12809 1/20 0.40
BACE2 Q9Y5Z0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18561593 0.86 BACE1 (0.55) BACE1APP
SCHEMBL18926585 0.84 BACE1 (0.59) BACE1APPKCNH2BACE2
SCHEMBL18927140 0.83 BACE1 (0.58) BACE1APP
SCHEMBL18927235 0.81 BACE1 (0.41) BACE1APPKCNH2BACE2
SCHEMBL932230 0.77 BACE1 (0.59) BACE1APPKCNH2BACE2
SCHEMBL18927162 0.73 BACE1 (0.52) BACE1APP
SCHEMBL931281 0.73 BACE1 (0.60) BACE1APPKCNH2BACE2
SCHEMBL932626 0.72 BACE1 (0.65) BACE1APPKCNH2BACE2
SCHEMBL19566751 0.71 APP (0.50) BACE1APP
SCHEMBL18927239 0.70 LMNA (0.33) BACE1APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3176172-B1 SPIROIMIDAZOLE COMPOUNDS AND THEIR USE AS BACE INHIBITORS ASTRAZENECA AB (SE) 2020-01-29 EP disclosed
EP-3176172-A1 SPIROIMIDAZOLE COMPOUNDS AND THEIR USE AS BACE INHIBITORS Astrazeneca AB (SE) 2017-06-07 EP disclosed